Harnessing the Gut Microbiome: To What Extent Can Pre-/Probiotics Alleviate Immune Activation in Autism Spectrum

Yuqi Wu1,2, Qi Su1,2

  • 1Microbiota I-Center (MagIC), Hong Kong SAR, China.

Nutrients
|August 10, 2024
PubMed

Insights

This review explores how gut bacteria influence autism spectrum disorder (ASD) symptoms and evaluates pre/probiotics for managing gastrointestinal issues and core ASD features. Further research is needed to confirm efficacy and establish treatment protocols.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology
  • Pediatrics

Background:

  • Children with autism spectrum disorder (ASD) frequently experience gastrointestinal (GI) discomfort, linked to the microbiome-gut-brain axis.
  • Gut microbiome alterations can trigger immune responses and gut-brain dysfunction, exacerbating ASD symptoms.
  • Existing research on pre/probiotics for ASD shows limited and conflicting results.

Purpose of the Study:

  • To comprehensively review the association between ASD clinical symptoms and specific bacterial taxa.
  • To evaluate the efficacy of pre/probiotics in modulating gut microbiota, reducing inflammation, and alleviating ASD-related symptoms.
  • To explore the potential of pre/probiotics in improving gut homeostasis, immune function, and nutritional status in ASD management.

Main Methods:

  • Systematic review of existing literature on the gut microbiome in ASD.
  • Analysis of studies investigating the effects of pre/probiotics on ASD symptoms, GI distress, sleep, and inflammation.
  • Evaluation of proposed mechanisms underlying pre/probiotic effects on the microbiome-gut-brain axis in ASD.

Main Results:

  • Specific bacterial taxa are associated with ASD symptoms, suggesting a role for the gut microbiome.
  • Pre/probiotics show potential in modulating microbiota composition and reducing inflammatory markers.
  • Evidence for significant improvement in core ASD symptoms, GI distress, and sleep problems remains limited and controversial.

Conclusions:

  • Pre/probiotic supplementation may offer a strategy to modulate gut homeostasis and immune responses in ASD.
  • Further well-designed randomized controlled trials are essential to confirm efficacy and establish optimal protocols.
  • Targeting the microbiome-gut-brain axis via pre/probiotics could be a complementary approach in managing ASD.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
78
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
403
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
124